International Journal of Molecular Sciences, 2019
AXIN1 in Plasma or Serum Is a Potential New Biomarker for Endometriosis

Ek M., Roth B., Engström G. et al.

Nephrology Dialysis Transplantation, 2019
Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years

Schulz CA, Engström G, Nilsson J et al.

Journal of NeuroVirology, 2019
Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease

Pulliam L., Sun B., Mustapic M. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2018
Proteins Altered by Surgical Weight Loss Highlight Biomarkers of Insulin Resistance in the Community

Shah R., Hwang S., Yeri A. et al.

EBioMedicine, 2018
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease

Bom M., Levin E., Driessen R. et al.

Diabetes and Vascular Disease Research, 2018
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease

Rattik S., Engelbertsen D., Wigren M. et al.

International Journal of Molecular Sciences, 2018
Wound-Healing Markers Revealed by Proximity Extension Assay in Tears of Patients following Glaucoma Surgery

Csősz ?., Tóth N., Deák E. et al.

Journal of Controlled Release, 2018
Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release

Sabhachandani P., Sarkar S., Mckenney S. et al.

Diabetes Care, 2018
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort

Schlesinger S., Herder C., Kannenberg J. et al.

Therapeutic Drug Monitoring, 2018
Targeted Proteomic Analysis Detects Acute T Cell–Mediated Kidney Allograft Rejection in Belatacept-Treated Patients

van der Zwan M., Hesselink D., Clahsen-van Groningen M. et al.

Biomarkers, 2018
The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients

Vroegindewey M., Oemrawsingh R., Kardys I. et al.

Clinical Proteomics, 2018
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Enroth S., Berggrund M., Lycke M. et al.

Journal of Nephrology, 2018
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease

Feldreich T., Nowak C., Fall T. et al.

Analytical Biochemistry, 2018
Protein measurements in venous plasma, earlobe capillary plasma and in plasma stored on filter paper

Siart B., de Oliveira F., Shen Q. et al.

Molecular Oncology, 2018
Protein profiling of fine‐needle aspirates reveals subtype‐associated immune signatures and involvement of chemokines in breast cancer

Franzén B., Alexeyenko A., Kamali‐Moghaddam M. et al.

Journal of the European Academy of Dermatology and Venereology, 2018
Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

Vossen A., van der Zee H., Davelaar N. et al.

European Heart Journal, 2018
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation

Chua W., Purmah Y., Cardoso V. et al.

ERJ Open Research, 2018
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension

Bouzina H., Rådegran G.

PLOS ONE, 2018
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

Gezelius E., Flou Kristensen A., Bendahl P. et al.

British Journal of Cancer, 2018
Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis

Qian J., Tikk K., Weigl K. et al.